Synthetic Bone Graft

Bioventus Gains FDA Clearance of SIGNAFUSE Bone Graft Strip

Bioventus Gains FDA Clearance of SIGNAFUSE Bone Graft Strip
Bioventus received FDA 510(k) clearance to market SIGNAFUSE® Bioactive Bone Graft in a strip format. The strips consist of 55% bioglass by weight and have been shown to induce higher levels of osteoblast differentiation compared to other synthetic bone graft strips....

Graftys Completes Capital Raise for Expansion

Graftys completed a ‚¬4.1MM (~US $4.6MM) funding round. Proceeds will support commercialization of QuickSet cement and HBS injectable calcium phosphate bone graft substitute.

BONESUPPORT Raises $37MM to Support Cerament

BONESUPPORT raised SEK 327MM (~US $37MM). Funds will support clinical data collection, product pipeline development and expansion of CERAMENT sales in existing and new markets.